Department of Biological Chemistry, Weizmann Institute of Science, 76100 Rehovot, Israel.
Dev Neurobiol. 2010 Apr;70(5):298-303. doi: 10.1002/dneu.20769.
The trk family of receptor tyrosine kinases supports survival and differentiation in the nervous system. Paradoxically it has also been shown that members of the trk family can induce cell death in pediatric tumor cells of neuronal origin. Moreover, TrkA and TrkC serve as good prognostic indicators in neuroblastoma and medulloblatoma, respectively. Although the possible linkage between these observations was intriguing, until recently there was limited insight on the mechanisms involved. Recent findings suggest that TrkA might influence neuronal cell death through stimulation of p75 cleavage. An alternative p75-independent mechanism was suggested by a newly discovered interaction between TrkA and CCM2 (the protein product of the gene cerebral cavernous malformation 2). Coexpression of CCM2 with TrkA induces cell death in medulloblastoma and neuroblastoma cells, and CCM2 expression levels correlate with those of TrkA and with good prognosis in neuroblastoma patients. Thus, mechanistic clues to the enigma of trk-induced cell death have begun to emerge. Detailed elucidation of these mechanisms and their in vivo physiological significance will be of keen interest for future research.
原肌球蛋白受体激酶家族(trk family of receptor tyrosine kinases)支持神经系统中的存活和分化。矛盾的是,也有研究表明 trk 家族成员可诱导神经元来源的小儿肿瘤细胞死亡。此外,TrkA 和 TrkC 分别作为神经母细胞瘤和髓母细胞瘤的良好预后指标。尽管这些观察结果之间可能存在关联,但直到最近,人们对相关机制的了解仍很有限。最近的研究结果表明,TrkA 可能通过刺激 p75 切割来影响神经元细胞死亡。另一种 p75 非依赖性机制是由新发现的 TrkA 与 CCM2(脑动静脉畸形 2 基因的蛋白产物)之间的相互作用所提示的。CCM2 与 TrkA 的共表达可诱导髓母细胞瘤和神经母细胞瘤细胞死亡,CCM2 的表达水平与 TrkA 的表达水平相关,并且与神经母细胞瘤患者的良好预后相关。因此,trk 诱导的细胞死亡之谜的机制线索开始显现。这些机制的详细阐明及其在体内的生理意义将是未来研究的热点。